News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,645 Results
Type
Article (8017)
Company Profile (140)
Press Release (476391)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166771)
Career Advice (306)
Deals (25740)
Drug Delivery (7)
Drug Development (52880)
Employer Resources (14)
FDA (9761)
Job Trends (8577)
News (238249)
Policy (17930)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33163)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10371)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (508)
Cancer (3636)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47858)
Collaboration (1241)
Commercialization (3)
Compensation (1459)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (743)
Cystic fibrosis (85)
Data (5636)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (342)
Diagnostics (4179)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73700)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87602)
Executive appointments (701)
FDA (12377)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (914)
Gene editing (125)
Generative AI (9)
Gene therapy (316)
GLP-1 (289)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9327)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (16)
Lung cancer (507)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (530)
Marketing (8)
MASH (118)
Medical device (8652)
Medtech (8793)
Mergers & acquisitions (14382)
Metabolic disorders (705)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1821)
NextGen: Class of 2026 (3153)
Non-profit (847)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (503)
Peanut (31)
People (41241)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15463)
Phase 2 (21373)
Phase 3 (14395)
Pipeline (7280)
Policy (18)
Postmarket research (1572)
Preclinical (6538)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3021)
Recruiting (6)
Regulatory (14814)
Reports (21)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (154)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (319)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (48)
Last 7 days (371)
Last 30 days (1674)
Last 365 days (19091)
2026 (12173)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34588)
2021 (37177)
2020 (33471)
2019 (23256)
2018 (17469)
2017 (18767)
2016 (17921)
2015 (24263)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20441)
2010 (20334)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17881)
Australia (2098)
California (11931)
Canada (3132)
China (519)
Colorado (482)
Connecticut (409)
Delaware (208)
Europe (24620)
Florida (1785)
Georgia (377)
Hawaii (3)
Idaho (46)
Illinois (695)
India (50)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1200)
Massachusetts (7839)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (81)
Montana (20)
Nebraska (11)
Nevada (115)
New Hampshire (60)
New Jersey (2616)
New Mexico (12)
New York (2817)
North Carolina (1270)
North Dakota (4)
Northern California (5975)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2246)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4954)
Tennessee (119)
Texas (1933)
United States (38761)
Utah (358)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (925)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,645 Results for "cryoport inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”
November 7, 2025
·
5 min read
Business
Cryoport Reports First Quarter 2024 Financial Results
Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences, today announced financial results for the three months ended March 31 (Q1), 2024.
May 7, 2024
·
19 min read
Business
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”), a global leader in supply chain solutions for cell & gene therapies, today announced financial results for the fourth quarter (Q4) and year (FY) ended December 31, 2023.
March 12, 2024
·
22 min read
Business
Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
Cryoport, Inc. today announced that the Company will report financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after U.S. markets close.
April 30, 2024
·
5 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Business
Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Cryoport, Inc. today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2023 on Tuesday, March 12, 2024 after U.S. markets close.
February 27, 2024
·
4 min read
Business
Cryoport Reports Second Quarter 2023 Financial Results
Cryoport, Inc. announced financial results for the second quarter and first half of 2023.
August 9, 2023
·
20 min read
Business
Cryoport Announces Multi-Year Agreement with Inception Fertility
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry and a leader in supply chain solutions for the reproductive medicine markets, announced a multi-year agreement with Inception Fertility™, North America’s largest provider of comprehensive fertility services.
March 28, 2023
·
5 min read
Business
Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023
Cryoport, Inc. today announced that the Company will report financial results for the third quarter ended September 30, 2023 on Wednesday, November 8, 2023 after U.S. markets close.
October 25, 2023
·
4 min read
Business
Cryoport Reports First Quarter 2023 Results
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences, announced financial results for the three months ended March 31, 2023.
May 4, 2023
·
26 min read
1 of 48,465
Next
